ANIXA BIOSCIENCES, INC. Accounts Payable
ANIXA BIOSCIENCES, INC. (ANIX) had Accounts Payable of $282.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-09-09
- 2026-07-31: Accounts Payable, Current $282.00K.
- 2026-04-30: Accounts Payable, Current $252.00K.
- 2026-01-31: Accounts Payable, Current $148.00K.
- 2025-10-31: Accounts Payable, Current $165.00K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-07-31 | $282.00K 10-Q · filed 2026-09-09 | |
| 2026-04-30 | $252.00K 10-Q · filed 2026-06-10 | |
| 2026-01-31 | $148.00K 10-Q · filed 2026-03-09 | |
| 2025-10-31 | $165.00K 10-Q · filed 2026-09-09 | |
| 2025-07-31 | $276.00K 10-Q · filed 2025-09-10 | |
| 2025-04-30 | $284.00K 10-Q · filed 2025-05-28 | |
| 2025-01-31 | $600.00K 10-Q · filed 2025-03-11 | |
| 2024-10-31 | $525.00K 10-K · filed 2026-01-12 | |
| 2024-07-31 | $302.00K 10-Q · filed 2024-09-06 | |
| 2024-04-30 | $215.00K 10-Q · filed 2024-06-04 | |
| 2024-01-31 | $364.00K 10-Q · filed 2024-03-12 | |
| 2023-10-31 | $206.00K 10-K · filed 2025-01-10 | |
| 2023-07-31 | $94.00K 10-Q · filed 2023-09-06 | |
| 2023-04-30 | $195.00K 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $110.00K 10-Q · filed 2023-03-17 | |
| 2022-10-31 | $265.00K 10-K · filed 2024-01-16 | |
| 2022-07-31 | $227.00K 10-Q · filed 2022-09-09 | |
| 2022-04-30 | $93.00K 10-Q · filed 2022-06-10 | |
| 2022-01-31 | $504.00K 10-Q · filed 2022-03-11 | |
| 2021-10-31 | $136.00K 10-K · filed 2023-01-04 | $136.20K 10-K · filed 2022-01-04 |
| 2021-07-31 | $207.73K 10-Q · filed 2021-09-01 | |
| 2021-04-30 | $438.01K 10-Q · filed 2021-06-10 | |
| 2021-01-31 | $511.82K 10-Q · filed 2021-03-11 | |
| 2020-10-31 | $232.37K 10-K · filed 2022-01-04 | |
| 2020-07-31 | $339.30K 10-Q · filed 2020-09-08 | |
| 2020-04-30 | $170.78K 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $367.10K 10-Q · filed 2020-03-09 | |
| 2019-10-31 | $585.82K 10-K · filed 2021-01-07 | |
| 2019-07-31 | $567.78K 10-Q · filed 2019-09-06 | |
| 2019-04-30 | $717.92K 10-Q · filed 2019-06-12 | |
| 2019-01-31 | $612.94K 10-Q · filed 2019-03-13 | |
| 2018-10-31 | $582.01K 10-K · filed 2020-01-09 | |
| 2018-07-31 | $419.41K 10-Q · filed 2018-09-07 | |
| 2018-04-30 | $452.11K 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $416.93K 10-Q · filed 2018-03-09 | |
| 2017-10-31 | $480.32K 10-K · filed 2019-01-11 | |
| 2017-07-31 | $444.75K 10-Q · filed 2017-09-08 | |
| 2017-04-30 | $448.35K 10-Q · filed 2017-05-26 | |
| 2017-01-31 | $540.68K 10-Q · filed 2017-03-16 | |
| 2016-10-31 | $373.22K 10-K · filed 2018-01-09 | |
| 2016-07-31 | $444.82K 10-Q · filed 2016-08-19 | |
| 2016-04-30 | $418.11K 10-Q · filed 2016-05-20 | |
| 2016-01-31 | $560.41K 10-Q · filed 2016-02-19 | |
| 2015-10-31 | $374.70K 10-K · filed 2016-12-08 | |
| 2015-07-31 | $424.69K 10-Q · filed 2015-08-18 | |
| 2015-04-30 | $388.79K 10-Q · filed 2015-05-22 | |
| 2015-01-31 | $577.61K 10-Q · filed 2015-03-09 | |
| 2014-10-31 | $540.18K 10-K · filed 2015-12-23 | |
| 2014-07-31 | $529.34K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $457.76K 10-Q · filed 2014-06-16 | |
| 2014-01-31 | $491.77K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $527.21K 10-K · filed 2015-01-29 | |
| 2013-07-31 | $516.04K 10-Q/A · filed 2013-09-20 | |
| 2013-04-30 | $534.05K 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | $489.22K 10-Q/A · filed 2013-03-25 | |
| 2012-10-31 | $304.52K 10-K/A · filed 2014-01-17 | |
| 2012-07-31 | $462.86K 10-Q · filed 2012-09-14 | |
| 2012-04-30 | $558.74K 10-Q · filed 2012-06-14 | |
| 2012-01-31 | $449.14K 10-Q · filed 2012-03-16 | |
| 2011-10-31 | $374.69K 10-K · filed 2013-01-29 | |
| 2011-07-31 | $278.41K 10-Q/A · filed 2011-10-14 | |
| 2010-10-31 | $355.68K 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |